L
Long Chen
Researcher at Beijing University of Chemical Technology
Publications - 28
Citations - 377
Long Chen is an academic researcher from Beijing University of Chemical Technology. The author has contributed to research in topics: Peptide & Medicine. The author has an hindex of 10, co-authored 18 publications receiving 237 citations.
Papers
More filters
Journal ArticleDOI
Role of peptide self-assembly in antimicrobial peptides.
TL;DR: The influences of peptide self‐assembly on the activity and mode of action, and some specific features it introduces to the AMPs, such as particular responsiveness, improved cell selectivity and stability and sustained release are discussed.
Journal ArticleDOI
A direct determination of AFBs in vinegar by aptamer-based surface plasmon resonance biosensor.
Wenbo Wu,Zhiling Zhu,Bingjie Li,Zhuqing Liu,Lili Jia,Limin Zuo,Long Chen,Zhentai Zhu,Guangzhi Shan,Shi-Zhong Luo +9 more
TL;DR: The developed SPR assay is a simple, fast and sensitive approach for the detection of residual AFBs in agricultural products and foodstuffs like vinegar, and shows high specificity towards AFB1 and AFB2, but hardly bound to other toxins with similar structures.
Journal ArticleDOI
Amyloid-Forming Segment Induces Aggregation of FUS-LC Domain from Phase Separation Modulated by Site-Specific Phosphorylation
Xiufang Ding,Fude Sun,Jialin Chen,Long Chen,Yuto Tobin-Miyaji,Song Xue,Wei Qiang,Shi-Zhong Luo +7 more
TL;DR: The RNA-binding protein fused in sarcoma (FUS) forms physiological granules and pathological fibrils, which facilitate RNA functions and cause neurodegenerative diseases, respectively, and Solid-state NMR spectroscopy and computational modeling implied that site-specific phosphorylation at Ser61 plays key roles in FUS assembly by disrupting both intra- and intermolecular interactions that maintain the amyloid core structure.
Journal ArticleDOI
Self-assembly nanostructure controlled sustained release, activity and stability of peptide drugs.
TL;DR: The self-assembly approach demonstrated in this study can be applied to a variety of therapeutic peptide drugs to improve their stability and therapeutic activity for the development of carrier-free drug delivery system.
Journal ArticleDOI
A novel antimicrobial peptide against dental-caries-associated bacteria.
Long Chen,Lili Jia,Qiang Zhang,Xi-Rui Zhou,Zhuqing Liu,Bingjie Li,Zhentai Zhu,Fenwei Wang,Changyuan Yu,Qian Zhang,Feng Chen,Shi-Zhong Luo +11 more
TL;DR: ZXR-2 showed broad-spectrum activity against a variety of Gram-positive and Gram-negative oral bacteria, particularly the caries-related taxa Streptococcus mutans, and represents a potential therapeutic for the prevention and treatment of dental caries.